This post was originally published on this site
https://i-invdn-com.akamaized.net/trkd-images/LYNXNPEG7D028_L.jpg
The German biotechnology firm sold 13.33 million shares at $16 apiece, the top end of its indicated price range, the source said, requesting anonymity ahead of an initial announcement. The company’s shares are set to trade in New York on Friday.
CureVac did not immediately respond to a request for comment.
